Haloperidol Injection 5 mg/mL Single Dose Vials for Intramuscular Use, 25/pk (Rx)

Rapid, Reliable Control of Acute Agitation, Psychosis & Severe Behavioral Disturbances

Haloperidol Injection 5 mg/mL by Mylan Pharmaceuticals is a hospital-trusted, fast-acting antipsychotic solution designed to provide immediate management of acute psychiatric emergencies. Specifically formulated for intramuscular (IM) administration, this single-dose vial ensures precise, sterile dosing for healthcare professionals in emergency rooms, psychiatric facilities, and critical care settings.

Haloperidol injection is a high-potency, first-generation antipsychotic widely used for:

• Acute agitation and psychotic episodes, including schizophrenia and schizoaffective states
• Emergency sedation of highly disruptive, violent, or aggressive behavior in psychiatric and medical patients
• Acute mania and hyperactive delirium in adults
• Short-term adjunct in severe behavioral disturbances in pediatric patients (use per prescriber’s guidelines)
• Management of severe symptoms in Tourette’s syndrome and tics

Haloperidol IM provides fast-acting, short-term control of symptoms when patient cooperation, oral administration, or reliable absorption is not possible—essential for crisis intervention and rapid de-escalation in medical and psychiatric emergencies.

Key Benefits & Features

• Powerful Antipsychotic: Clinically proven butyrophenone antipsychotic for rapid stabilization of acute psychosis, severe agitation, and delirium.
• Rapid Onset Action: Achieves quick symptom control when oral medications are not an option or in patients who refuse or cannot take oral therapy.
• Single-Dose Vial for IM Use: Guarantees sterile, precise, and ready-to-use medication, reducing medication errors and cross-contamination in high-acuity or urgent care environments.
• Versatile Applications: Indicated for schizophrenia, acute manic episodes, hyperactive delirium, acute psychotic disorders, severe behavioral issues, and Tourette’s syndrome.
• Hospital-Grade Quality: Manufactured by Mylan Pharmaceuticals, a global leader in injectable hospital medications and psychiatry support drugs.

Directions for Use

• For intramuscular use only. Single-dose vial.
• Dosage must be individualized based on the patient’s condition, age, and response.
• Adult dosing for acute agitation or psychosis is typically 2–5 mg IM, repeatable as needed at appropriate intervals, not to exceed recommended maximums (always follow official prescribing information and institutional protocol).
• For use by healthcare professionals only.
• Monitor for response, side effects, and adverse reactions as per clinical guidelines.

Why Choose Haloperidol Injection by Mylan Pharmaceuticals?

• Rapid symptom control in medical and psychiatric emergencies
• High-quality, single-use, premeasured sterile vials ensure safe administration
• Manufacturer you can trust—commitment to purity, potency, and performance
• Indispensable for ERs, psychiatric hospitals, acute care, crisis intervention, and correctional medicine

Important Safety & Health Information

• Warnings: May cause extrapyramidal symptoms (EPS), QT prolongation, neuroleptic malignant syndrome (NMS), or severe hypotension. Use with extreme caution in elderly patients with dementia-related psychosis.
• Contraindications: Severe CNS depression, known sensitivity to haloperidol or butyrophenones, Parkinson’s disease, comatose states.
• Monitor closely for movement disorders, ECG changes, cardiac status, and adverse reactions.
• Not for intravenous use.

Bring rapid stability to acute psychiatric disturbances—choose Haloperidol Injection 5 mg/mL, Single-Dose Vials by Mylan Pharmaceuticals for trusted, hospital-grade antipsychotic control where and when it matters most.